is cagrilintide a glp-1 Cagrilintide: The Next-Gen Peptide for Weight Loss and Satiety Semaglutide, a glucagon-like peptide-1 (GLP-1)

Peptides: Tesamorelin, AOD9604, Tirzepatide (GLP-1 agonist) Tesamorelin is FDA-approved to reduce visceral adipose tissue (VAT) in HIV-associated lipodystrophy, but its fat-burning effects also appear in non-HIV populations AOD9604 is a modified fragment of human GH (176191) shown in animal and early human trials to enhance lipolysis without altering blood sugar or cortisol Tirzepatide , while technically a GLP-1/GIP agonist , is now frequently stacked with peptides in clinical practice to accelerate fat loss and appetite control

However, optimal doses appear tissue- and application-specific, with lower doses often sufficient for gastrointestinal applications while musculoskeletal injuries may benefit from higher dosing

JAMA Netw Open 2021;4(9):e2125725

(2) K.Skrlec et al (2018) Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities Applied Microbiology and Biotechnology, Volume 102, pages 1010310117, (06 September 2018)